Temporal Effects of Ethanol Consumption on Energy Homeostasis, Hepatic Steatosis, and Insulin Sensitivity in Mice
Article first published online: 7 FEB 2013
Copyright © 2013 by the Research Society on Alcoholism
Alcoholism: Clinical and Experimental Research
Volume 37, Issue 7, pages 1091–1099, July 2013
How to Cite
Carr, R. M., Dhir, R., Yin, X., Agarwal, B. and Ahima, R. S. (2013), Temporal Effects of Ethanol Consumption on Energy Homeostasis, Hepatic Steatosis, and Insulin Sensitivity in Mice. Alcoholism: Clinical and Experimental Research, 37: 1091–1099. doi: 10.1111/acer.12075
- Issue published online: 3 JUL 2013
- Article first published online: 7 FEB 2013
- Manuscript Accepted: 20 NOV 2012
- Manuscript Received: 12 SEP 2012
- National Institutes of Health (NIH). Grant Number: P01-DK-049210
- Diabetes Research Center Mouse Metabolic Phenotyping Core. Grant Number: P30-DK-19525
- Center for Molecular Studies of Digestive and Liver Disease Morphology Core. Grant Number: P30-DK-50306
- NIH Training. Grant Number: T32-DK-007066
- National Center for Research Resources and the Office of the Director of the NIH. Grant Number: C06 RR018823
- Alcoholic Steatosis;
- Insulin Resistance;
- Perilipin 2;
- Metabolic Pheno-typing
Alcoholic liver disease (ALD) progresses from steatosis to inflammation, fibrosis, and cirrhosis. Although ALD has been associated with insulin resistance, it is unclear whether insulin resistance coincides with the development of steatosis.
We studied the temporal relationship of steatosis and glucose homeostasis in mice fed a Lieber–DeCarli liquid control or ethanol (EtOH) diet for 2, 4, or 8 weeks. We studied the effects of alcohol consumption on energy balance, body composition, and hepatic lipids. Glucose tolerance test was performed, and insulin sensitivity was evaluated with hyperinsulinemic-euglycemic clamp.
EtOH-fed mice developed hepatic steatosis over time as compared with control-fed mice despite similar energy intake and expenditure, and gain in body weight and fat. EtOH-fed mice developed glucose intolerance as early as 2 weeks, while insulin resistance developed at 4 weeks. A hyperinsulinemic clamp study at 8 weeks revealed both hepatic and peripheral insulin resistance in EtOH-fed mice. Insulin resistance was associated with hepatic steatosis, increased ceramide levels, and Perilipin 2 expression.
Chronic EtOH consumption leads to the development of hepatic steatosis, impaired glucose tolerance, and insulin resistance. These changes are independent of energy intake or expenditure, weight, whole body fat content, and inflammation. A better understanding of the processes linking EtOH-induced steatosis and abnormal glucose homeostasis may lead to novel therapies targeting the progression of ALD.